Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus

Experimental and Molecular Medicine

Volumn 40, Issue 5, 2008, Pages 523-532

  Yoon, Shin Cho ^a   Min, Jin Go ^a   Hye, Ree Han ^a   Cha, Seung Hun ^a   Kim, Hung Tae ^a   Min, Haesook ^a   Hyoung, Doo Shin ^b   Park, Chan ^a   Han, Bok Ghee ^a   Nam, Han Cho ^c   Shin, Chol ^d   Kimm, Kuchan ^a   Oh, Bermseok ^a,e  

^a Korea National Institute of Health   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Kyung Hee University Hospital   (South Korea)

Author keywords

Asian continental ancestry group; Diabetes mellitus, type 2; Haplotypes; Lipoprotein lipase; Polymorphism, single nucleotide

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 57349121077     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2008.40.5.523     Document Type: Article

References (42)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53
2. Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet 2005;42:737-48
3. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5
4. Chen P, Jou YS, Fann CS, Chen JW, Wu SY, Pan WH. Lipoprotein lipase gene is linked and associated with hypertension in Taiwan young-onset hypertension genetic study. J Biomed Sci 2005;12:651-8
5. de Vries R, Borggreve SE, Dullaart RP. Role of lipases, lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. Clin Lab 2003;49:601-13
6. Forner K, Lamarine M, Guedj M, Dauvillier J, Wojcik J. Universal false discovery rate estimation methodology for genome-wide association studies. Hum Hered 2008;65:183-94
7. Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002;155:478-84
8. Hao K, Di X, Cawley S. LdCompare: rapid computation of single- and multiple-marker r2 and genetic coverage. Bioinformatics 2007;23:252-4
9. Hoffer MJ, Bredie SJ, Snieder H, Reymer PW, Demacker PN, Havekes LM, Boomsma DI, Stalenhoef AF, Frants RR, Kastelein JJ. Gender-related association between the -93T->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia. Atherosclerosis 1998;138:91-9
10. Hurd C, Ocheja A, Cheetham-Wilkinson C, Ouwehand W. HPA-1, -2 and -3 genotyping using the TaqMan reaction. Transfusion Medicine 2000;10:326-6
11. Javorsky M, Kozarova M, Salagovic J, Tkac I. Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients. Physiol Res 2006;55:55-62
12. Julien P, Gagne C, Murthy MR, Levesque G, Moorjani S, Cadelis F, Hayden MR, Lupien PJ. Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population. Hum Mutat 1998;Suppl 1:S148-53
13. Kalmar T, Seres I, Balogh Z, Kaplar M, Winkler G, Paragh G. Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus. Diabetes Metab 2005;31:574-80
14. Klannemark M, Suurinkeroinen L, Orho-Melander M, Groop L, Taskinen MR. Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus. Diabet Med 2000;17:599-605
15. Li B, Ge D, Wang Y, Zhao W, Zhou X, Gu D, Chen R. Lipoprotein lipase gene polymorphisms and blood pressure levels in the Northern Chinese Han population. Hypertens Res 2004;27:373-8
16. Liao G, Wang J, Guo J, Allard J, Cheng J, Ng A, Shafer S, Puech A, McPherson JD, Foernzler D, Peltz G, Usuka J. In silico genetics: identification of a functional element regulating H2-Ealpha gene expression. Science 2004;306:690-5
17. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005;307:384-7
18. Ma YQ, Thomas GN, Ng MC, Critchley JA, Chan JC, Tomlinson B. The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients. Metabolism 2003;52:338-43
19. Marcais C, Bernard S, Merlin M, Ulhmann M, Mestre B, Rochet-Mingret L, Revol A, Berthezene F, Moulin P. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency. Diabetologia 2000;43:1346-52
20. Mattu RK, Trevelyan J, Needham EW, Khan M, Adiseshiah MA, Richter D, Murray RG, Betteridge DJ. Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes. Diabetologia 2002;45:905-13
21. McPherson R, Jones PH. The metabolic syndrome and type 2 diabetes: role of the adipocyte. Curr Opin Lipidol 2003;14:549-53
22. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 2002;80:753-69
23. Mingrone G, Henriksen FL, Greco AV, Krogh LN, Capristo E, Gastaldelli A, Castagneto M, Ferrannini E, Gasbarrini G, Beck-Nielsen H. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes 1999;48:1258-63
24. Ng MC, Baum L, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpaintner K, Chan JC. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T > C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet 2006;70:20-8
25. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997;25:2745-51
26. Pillarisetti S, Saxena U. Lipoprotein lipase as a therapeutic target for dyslipidemia. Front Biosci 2003;8:d238-41
27. Pounds S, Cheng C. Robust estimation of the false discovery rate. Bioinformatics 2006;22:1979-87
28. Pruneta-Deloche V, Marcais C, Perrot L, Sassolas A, Delay M, Estour B, Lagarde M, Moulin P. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia. J Clin Endocrinol Metab 2005;90:3995-8
29. Radha V, Vimaleswaran KS, Ayyappa KA, Mohan V. Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population. Int J Obes (Lond) 2007;31:913-8
30. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86
31. Socquard E, Durlach A, Clavel C, Nazeyrollas P, Durlach V. Association of HindIII and PvuII genetic polymorphisms of lipoprotein lipase with lipid metabolism and macrovascular events in type 2 diabetic patients. Diabetes Metab Rev 2006;32:262-9
32. Solini A, Passaro A, Fioretto P, Nannipieri M, Ferrannini E. Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes. J Intern Med 2004;256:30-6
33. Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Pike MC. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003;55:27-36
34. Taskinen MR. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992;41:12-7
35. Taskinen MR. Lipoprotein lipase in diabetes. Diabetes Metab Rev 1987;3:551-70
36. Taskinen MR. Diabetic dyslipidemia: from basic research to clinical practice. Diabetologia 2003;46:733-49
37. Tiffin N, Adie E, Turner F, Brunner HG, van Driel MA, Oti M, Lopez-Bigas N, Ouzounis C, Perez-Iratxeta C, Andrade-Navarro MA, Adeyemo A, Patti ME, Semple CA, Hide W. Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes. Nucleic Acids Res 2006;34:3067-81
38. Tkac I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Res Clin Pract Suppl1 2005:S2-9
39. Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kesaniemi YA. DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. Atherosclerosis 1995;115:99-05
40. Williams RR, Hunt SC, Hopkins PN, Wu LL, Lalouel JM. Evidence for single gene contributions to hypertension and lipid disturbances: definition, genetics, and clinical significance. Clin Genet 1994;46:80-7
41. Yang T, Pang CP, Tsang MW, Lam CW, Poon PM, Chan LY, Wu XQ, Tomlinson B, Baum L. Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes. Hum Mutat 2003a;21:453-62
42. Yang W, Huang J, Ge D, Yao C, Duan X, Gan W, Huang G, Zhao J, Hui R, Shen Y, Qiang B, Gu D. Variation near the region of the lipoprotein lipase gene and hypertension or blood pressure levels in Chinese. Hypertens Res 2003b;26:459-64